SUBJECTS : Skin Pharmacology | Skin Disorders | Aesthetic Dermatology | Dermatological Surgery | Dermatolog
Dermatology and Therapy: 2023, vol: , issue:
- 1)- James Choe, John S Barbieri. Emerging Medical Therapies in Rosacea: A Narrative Review. Dermatology and therapy. 2023, 13 (12): 2933-2949
Cited : 3Read More - 2)- Alexander Egeberg, Louise Linsell, Erin Johansson, Frederick Durand, Guanglei Yu, Sergio Vañó-Galván. Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review. Dermatology and therapy. 2023, 13 (12): 2951-2991Cited : 3Read More
- 3)- Alan S Shen, Jessica S Johnson, Michelle Lynn Kerns. Dietary Factors and Hidradenitis Suppurativa. Dermatology and therapy. 2023, 13 (12): 3007-3017Cited : 1Read More
- 4)- Jonathan I Silverberg, Selwyn Ho, Raúl Collazo. A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials? Dermatology and therapy. 2023, 13 (12): 3019-3029Cited : 3Read More
- 5)- Andrew Blauvelt, Richard G Langley, Kenneth B Gordon, Jonathan I Silverberg, Kilian Eyerich, Morten O A Sommer, Jakob Felding, Richard B Warren. Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review. Dermatology and therapy. 2023, 13 (12): 3031-3042Cited : 4Read More
- 6)- Paula C Luna, Chia-Yu Chu, Mohammad Fatani, Cecilia Borlenghi, Anna Adora, Lyndon Q Llamado, James Wee. Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis. Dermatology and therapy. 2023, 13 (12): 3043-3055Cited : 3Read More
- 7)- Russell Wong, Angela Murphy, Monica Lira, Mariangela G de O Sichmann, Alexis R Kim, Veronica D Saechee, Kevin D Hermanson, Stacy S Hawkins. Microneedling with a Novel, n-3-PUFA-Rich Formulation Accelerates Inflammation Resolution to Improve Skin Recovery Outcomes in Adults with Healthy Skin. Dermatology and therapy. 2023, 13 (12): 3057-3069Cited : 0Read More
- 8)- Chengbei Bao, Yan Zhao, Renwei Luo, Qiuyun Xu, Zequn Tong, Zhixun Xiao, Zheyu Zhuang, Wenjia Dai, Bohan Gu, Ting Gong, Bo Cheng, Chao Ji. Application and Comparison of Dermoscopy and Reflectance Confocal Microscopy in the Target Treatment of Genital Lichen Sclerosus: A Single-Arm Prospective Study. Dermatology and therapy. 2023, 13 (12): 3071-3084Cited : 1Read More
- 9)- Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson, Sunil Dhawan, Rajeev Chavda, J P York, Baldo Sforzolini, Kate Holcomb, Glynis Ablon, James Del Rosso, Brigitte Dreno. Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study. Dermatology and therapy. 2023, 13 (12): 3085-3096Cited : 5Read More
- 10)- Tsen-Fang Tsai, Min Zheng, Yangfeng Ding, Zhiqi Song, Quanzhong Liu, Ying Chen, Hanzhao Hu, Jinhua Xu. Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial. Dermatology and therapy. 2023, 13 (12): 3097-3110Cited : 1Read More
- 11)- Zoe Diana Draelos, Isabel Diaz. The Benefits of a Multimechanistic Antiaging Skin Technology. Dermatology and therapy. 2023, 13 (12): 3111-3119Cited : 0Read More
- 12)- Marie-Dominique Thouvenin, Adeline Bacquey, Marine Babin, Fabrice Lestienne, Christophe Lauze, Eléonore Gravier, Diana Placintescu, Ariadna Ortiz-Brugués, Sonja Ständer. Efficacy of Avène Hydrotherapy on Chronic Pruritus in Patients with Plaque Psoriasis. Dermatology and therapy. 2023, 13 (12): 3137-3151Cited : 0Read More
- 13)- Shan Jing, Yang Lin, Randy Dockens, David Marchisin, Bing He, Ihab G Girgis, Anjaneya Chimalakonda, Bindu Murthy, Urvi Aras. Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects. Dermatology and therapy. 2023, 13 (12): 3153-3164Cited : 0Read More
- 14)- Hao Trong Nguyen, Anh Tuan Vu, Nhi Thi Uyen Pham, Tu Nguyen Anh Tran, Nguyen Nhat Pham, Huong Thi Thanh Bui, Thuyen Thi Pham, Vi Thi Thuy Dinh, Yen Thi Bui, Thao Thi Phuong Vu. Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study. Dermatology and therapy. 2023, 13 (12): 3193-3208Cited : 0Read More
- 15)- Maryanne M Senna, Ohsang Kwon, Bianca M Piraccini, Rodney Sinclair, Susan Ball, Yuxin Ding, Yun-Fei Chen, Yves Dutronc, Brett King. Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata. Dermatology and therapy. 2023, 13 (12): 3209-3220Cited : 0Read More
- 16)- Rachel E Tao, Jessica N Pixley, Phillip G Holovach, Alan B Fleischer, Steven R Feldman. Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS). Dermatology and therapy. 2023, 13 (12): 3221-3227Cited : 0Read More
- 17)- Howa Yeung, Yin Li, Robert A Swerlick. The Changing Tasks of Medicine and Dermatology in the Twenty-First Century: The Need for Improved Information Capture Tools and Processes. Dermatology and therapy. 2023, 13 (11): 2479-2486Cited : 0Read More
- 18)- Hannah Penton, Sayeli Jayade, Santhani Selveindran, Marieke Heisen, Christophe Piketty, Liliana Ulianov, Zarif K Jabbar-Lopez, Jonathan I Silverberg, Jorge Puelles. Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials. Dermatology and therapy. 2023, 13 (11): 2549-2571Cited : 0Read More
- 19)- Thomas B Casale, Ana Maria Gimenez-Arnau, Jonathan A Bernstein, Michael Holden, Torsten Zuberbier, Marcus Maurer. Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status. Dermatology and therapy. 2023, 13 (11): 2573-2588Cited : 4Read More
- 20)- April W Armstrong, Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, Viktor Chirikov. Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Dermatology and therapy. 2023, 13 (11): 2605-2607Cited : 0Read More
- 21)- Michael J Cork, Diamant Thaçi, Lawrence F Eichenfield, Peter D Arkwright, Zhen Chen, Ryan B Thomas, Matthew P Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A Levit. Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis. Dermatology and therapy. 2023, 13 (11): 2697-2719Cited : 4Read More
- 22)- Byung Soo Kim, Seong Jin Jo, SangWoong Youn, Kristian Reich, Carine Saadoun, Chia-Ling Chang, Ya-Wen Yang, Yu-Huei Huang, Tsen-Fang Tsai. Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2. Dermatology and therapy. 2023, 13 (11): 2721-2737Cited : 0Read More
- 23)- Robert R McLean, Adam P Sima, Silky Beaty, Robert Low, Rebecca L Spitzer, Jeffrey L Stark, Elizabeth Lesser, Edward Lee, April Armstrong. Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatology and therapy. 2023, 13 (11): 2739-2751Cited : 0Read More
- 24)- Robert R McLean, Adam P Sima, Silky Beaty, Eric A Jones, Thomas Eckmann, Robert Low, Laura McClung, Rebecca L Spitzer, Jeffrey Stark, April Armstrong. Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatology and therapy. 2023, 13 (11): 2753-2768Cited : 2Read More
- 25)- Serena Manara, Francesco Beghini, Giulia Masetti, Federica Armanini, Davide Geat, Giulia Galligioni, Nicola Segata, Stefania Farina, Mario Cristofolini. Thermal Therapy Modulation of the Psoriasis-Associated Skin and Gut Microbiome. Dermatology and therapy. 2023, 13 (11): 2769-2783Cited : 4Read More
- 26)- Kinga Tyczyńska, Piotr K Krajewski, Danuta Nowicka-Suszko, Dariusz Janczak, Hanna Augustyniak-Bartosik, Magdalena Krajewska, Jacek C Szepietowski. Neurotrophin-4 and Brain-Derived Neurotrophic Factor Serum Levels in Renal Transplant Recipients with Chronic Pruritus. Dermatology and therapy. 2023, 13 (11): 2785-2796Cited : 0Read More
- 27)- Ericles Andrei Bellei, André Vicente Esteves de Carvalho, Beatriz Magalhães Eng, Carla Tozato, Danilo Hamilko de Barros, Erika Yumi Tamashiro, Gleison Vieira Duarte, Rafael Toledo Rodrigues de Fátima, Renata Ferreira Magalhães, Roberto Souto da Silva, Wagner Guimarães Galvão Cesar, Felipe Garutti Thies. Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms. Dermatology and therapy. 2023, 13 (11): 2797-2815Cited : 0Read More
- 28)- Aoife Mahon-Smith, George Skingley, Lara Ayala-Nunes, Anjali Batish, Rosie Sharp, Christel Naujoks, Eva Schruf, Nicolò Compagno, Santiago G Moreno. Evaluating the Appropriateness of Existing Health-Related Quality of Life Measures in Lichen Planus. Dermatology and therapy. 2023, 13 (11): 2817-2837Cited : 0Read More
- 29)- April W Armstrong, Richard B Warren, Yichen Zhong, Joe Zhuo, Allie Cichewicz, Ananth Kadambi, Daniela Junqueira, Tracy Westley, Renata Kisa, Carolin Daamen, Matthias Augustin. Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis. Dermatology and therapy. 2023, 13 (11): 2839-2857Cited : 7Read More
- 30)- Riley K Spencer, Joy Q Jin, Kareem G Elhage, Mitchell S Davis, Marwa Hakimi, George Gondo, Wilson Liao, Tina Bhutani. Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation. Dermatology and therapy. 2023, 13 (11): 2903-2909Cited : 0Read More
- 31)- Andrew Blauvelt, Alyssa Garrelts, William Malatestinic, Julie Birt, Baojin Zhu, Meghan Feely. Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA. Dermatology and therapy. 2023, 13 (11): 2911-2916Cited : 1Read More
- 32)- Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R Feldman. Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA. Dermatology and therapy. 2023, 13 (11): 2917-2923Cited : 1Read More
- 33)- Norito Katoh, Masanori Ikeda, Yukihiro Ohya, Hiroyuki Murota, Xiaofei Hu, John Liu, Hayato Niiyama, Takuya Sasaki, Eliza M Raymundo, Hidehisa Saeki. Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study. Dermatology and therapy. 2023, : Cited : 1Read More
- 34)- Kathyana P Santiago Mangual, Sarah Ferree, Jenny E Murase, Arianne Shadi Kourosh. The Burden of Air Pollution on Skin Health: a Brief Report and Call to Action. Dermatology and therapy. 2023, : Cited : 1Read More
- 35)- Anna Swenson, Jessica K Paulus, Yoojin Jung, Stefan Weiss, Brian Berman, Elena Peeva, Yuji Yamaguchi, Prethibha George, Oladayo Jagun. Natural History of Keloids: A Sociodemographic Analysis Using Structured and Unstructured Data. Dermatology and therapy. 2023, : Cited : 0Read More
- 36)- Anna Balato, Francesca Ambrogio, Martina Burlando, Carlo Giovanni Carrera, Andrea Chiricozzi, Maria Esposito, Stefano Piaserico, Miriam Teoli, Paolo Gisondi. Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice. Dermatology and therapy. 2023, : Cited : 2Read More
- 37)- Mitchell S Davis, Riley K Spencer, Chandler E Johnson, Kareem G Elhage, Joy Q Jin, Marwa Hakimi, Tina Bhutani, Wilson Liao. Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies. Dermatology and therapy. 2023, : Cited : 4Read More
- 38)- Enzo Errichetti, Alen Zabotti. Biologics in Prevention of Psoriasis to Psoriatic Arthritis Transition: The Need of Prospective Analyses and Stratification According to Time-Related Risk Factors. Dermatology and therapy. 2023, : Cited : 2Read More
- 39)- Spyridon Gkalpakiotis, Martina Kojanová, Jorga Fialová, Petra Cetkovská, Vladimír Vašků, Yvetta Vantuchová, Alena Machovcová, Petra Gkalpakioti, Pavla Hrdá, Petr Arenberger. Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic. Dermatology and therapy. 2023, : Cited : 0Read More
- 40)- Yayoi Tada, Ahmed M Soliman, Kanako Ishii, Ryuta Sakuma, Luis Puig, Matthew Davis, Dominic Nunag, Andreas Pinter, Shinichi Imafuku. Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan. Dermatology and therapy. 2023, : Cited : 2Read More
- 41)- Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos Armario-Hita. Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy. 2023, : Cited : 3Read More
